Combination of Vorinostat and caspase-8 inhibition exhibitshigh anti-tumoral activity on endometrial cancer cells

Thumbnail
View/Open
Issue date
2013
Author
Eritja Sánchez, Núria
Bergadà Bertran, Laura
Sorolla Bardají, Anabel
Yeramian Hakim, Andree
Mirantes, Cristina
Matias-Guiu, Xavier
Dolcet Roca, Xavier
Suggested citation
Eritja Sánchez, Núria; Bergadà Bertran, Laura; Sorolla Bardají, Anabel; Yeramian Hakim, Andree; Mirantes, Cristina; Matias-Guiu, Xavier; Dolcet Roca, Xavier; . (2013) . Combination of Vorinostat and caspase-8 inhibition exhibitshigh anti-tumoral activity on endometrial cancer cells. Molecular oncology, 2013, núm. 7, p. 763-775. https://doi.org/10.1016/j.molonc.2013.03.003.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Histone deacetylase inhibitors such as Vorinostat display anti-neoplastic activity against avariety of solid tumors. Here, we have investigated the anti-tumoral activity of Vorinostaton endometrial cancer cells. We have found that Vorinostat caused cell growth arrest, lossof clonogenic growth and apoptosis
of endometrial cancer cells. Vorinostat-induced theactivation of caspase-8 and -9, the initiators caspases of the extrinsic and the intrinsicapoptotic pathways, respectively. Next, we investigated the role of the extrinsic pathwayin apoptosis triggered by Vorinostat. We found that Vorinostat caused a dramatic decreaseof FLIP mRNA and protein levels. However, overexpression of the long from of FLIP did notblock Vorinostat-induced apoptosis. To further investigate the role of extrinsic apoptoticpathway in Vorinostat-induced apoptosis, we performed an shRNA-mediated knock-down of caspase-8. Surprisingly, downregulation of caspase-8 alone caused a markeddecrease in clonogenic ability and reduced the growth of endometrial cancer xenograftsin vivo, revealing that targeting caspase-8 may be an attractive target for anticancer ther-apy on endometrial tumors. Furthermore, combination of caspase-8 inhibition and Vorino-stat treatment caused an enhancement of apoptotic cell death and a further decrease ofclonogenic growth of endometrial cancer cells. More importantly, combination of Vorino-stat and caspase-8 inhibition caused a nearly complete inhibition of tumor xenograftgrowth. Finally, we demonstrate that cell death triggered by Vorinostat alone or incombination with caspase-8 shRNAs was inhibited by the anti-apoptotic protein Bcl-XL.Our results suggest that combinatory therapies using Vorinostat treatment and caspase-8 inhibition can be an effective treatment for endometrial carcinomas.
URI
http://hdl.handle.net/10459.1/64790
DOI
https://doi.org/10.1016/j.molonc.2013.03.003
Is part of
Molecular oncology, 2013, núm. 7, p. 763-775
Collections